We are live on ! Find out more
BFA

BlackRock Fund Advisors Portfolio holdings

AUM $542B
1-Year Est. Return 18.13%
This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+18.13%
3 Year Est. Return
+41.39%
5 Year Est. Return
10 Year Est. Return
AUM
$355B
AUM Growth
+$17.7B
Cap. Flow
+$3.38B
Cap. Flow %
0.95%
Top 10 Hldgs %
9.86%
Holding
4,000
New
139
Increased
1,720
Reduced
1,849
Closed
134

Sector Composition

Rank Sector Weight
1 Technology 12.61%
2 Healthcare 12.54%
3 Financials 12.33%
4 Industrials 11.48%
5 Energy 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTVCB
2726
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$6.07M ﹤0.01%
233,890
-27,957
-11% -$725K
EXAC
2727
DELISTED
Exactech Inc
EXAC
$6.07M ﹤0.01%
240,385
-20,582
-8% -$477K
LMNR icon
2728
Limoneira
LMNR
$244M
$6.06M ﹤0.01%
275,741
-3,827
-1% -$86K
BBNK
2729
DELISTED
BRIDGE CAPITAL HOLDINGS
BBNK
$6.05M ﹤0.01%
250,081
-22,808
-8% -$526K
PIKE
2730
DELISTED
PIKE CORPORATION COM STK (NC)
PIKE
$6.05M ﹤0.01%
675,054
-55,653
-8% -$520K
EGO icon
2731
Eldorado Gold
EGO
$8.33B
$6.03M ﹤0.01%
157,724
-3,294
-2% -$101K
LEE icon
2732
Lee Enterprises
LEE
$175M
$6.03M ﹤0.01%
135,395
+119,544
+754% +$5M
WIX icon
2733
WIX.com
WIX
$2.56B
$6.02M ﹤0.01%
303,357
+94,329
+45% +$1.78M
OPY icon
2734
Oppenheimer Holdings
OPY
$1.18B
$6M ﹤0.01%
249,996
-24,746
-9% -$609K
RVNC
2735
DELISTED
Revance Therapeutics, Inc.
RVNC
$6M ﹤0.01%
176,314
-13,433
-7% -$421K
MTSI icon
2736
MACOM Technology Solutions
MTSI
$17.4B
$5.98M ﹤0.01%
266,141
+2,921
+1% +$56.3K
CSS
2737
DELISTED
CSS Industries, Inc.
CSS
$5.94M ﹤0.01%
225,180
-15,646
-6% -$395K
VRNG
2738
DELISTED
VRINGO, INC COM STK NEW (DE)
VRNG
$5.92M ﹤0.01%
173,170
-13,263
-7% -$466K
FCBC icon
2739
First Community Bankshares
FCBC
$899M
$5.92M ﹤0.01%
412,925
-67,007
-14% -$992K
DWSN
2740
DELISTED
DAWSON GEOPHYSICAL CO
DWSN
$5.91M ﹤0.01%
206,366
-23,356
-10% -$652K
FLEX icon
2741
Flex
FLEX
$37.7B
$5.91M ﹤0.01%
708,549
+87,482
+14% +$659K
PWOD
2742
DELISTED
Penns Woods Bancorp
PWOD
$5.9M ﹤0.01%
187,964
-17,352
-8% -$524K
CRAI icon
2743
CRA International
CRAI
$1.23B
$5.89M ﹤0.01%
255,684
-30,987
-11% -$671K
HRTX icon
2744
Heron Therapeutics
HRTX
$93.4M
$5.89M ﹤0.01%
+478,271
New +$5.71M
FRPH icon
2745
FRP Holdings
FRPH
$439M
$5.89M ﹤0.01%
336,848
-32,338
-9% -$554K
NWBO
2746
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$5.88M ﹤0.01%
876,583
+789,219
+903% +$5.02M
INDY icon
2747
iShares S&P India Nifty 50 Index Fund
INDY
$558M
$5.86M ﹤0.01%
202,165
+1,074
+0.5% +$29.5K
PBPB
2748
DELISTED
Potbelly
PBPB
$5.85M ﹤0.01%
366,406
+149,150
+69% +$2.43M
MLR icon
2749
Miller Industries
MLR
$577M
$5.84M ﹤0.01%
283,780
-33,182
-10% -$654K
ALV icon
2750
Autoliv
ALV
$9.14B
$5.84M ﹤0.01%
76,026
+4,473
+6% +$334K

Similar funds

BlackRock Fund Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, BlackRock Fund Advisors held 4,000 positions worth $355B, up 5.2% from $337B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

BlackRock Fund Advisors's Q2 2014 filing shows 139 new, 1,720 increased, 1,849 reduced and 134 closed positions. Its largest new stake was Endo International plc: 6,053,196 shares worth $424M. The largest sale was Pentair, an estimated $199M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • BlackRock Fund Advisors's largest Q2 2014 buy was Endo International plc: 6,053,196 shares worth $424M.
  • BlackRock Fund Advisors added most to Wells Fargo in Q2 2014, an estimated $296M increase.
  • BlackRock Fund Advisors's biggest Q2 2014 reduction was FOREST LABORATORIES INC, cutting an estimated $191M.
  • BlackRock Fund Advisors fully exited Pentair in Q2 2014, selling an estimated $199M.
  • BlackRock Fund Advisors's ten largest holdings make up 9.9% of its $355B portfolio in Q2 2014.
  • BlackRock Fund Advisors opened 139 new positions and closed 134 in Q2 2014.
  • BlackRock Fund Advisors's portfolio value rose 5.2% quarter-over-quarter to $355B.

Based on BlackRock Fund Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.